Callao, Peru Clinical Trials

A listing of Callao, Peru clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 100 clinical trials
D9319C00001- 1L OC Mono Global RCT

This is a Phase III, randomised, double-blind, placebo-controlled, multicentre, international study assessing the efficacy and safety of maintenance olaparib compared with placebo in BRCAwt participants with Stage III to IV high grade serous or endometroid ovarian cancer (including fallopian tube cancer or primary peritoneal cancer) who are in complete or …

cancer antigen 125
primary debulking surgery
tumor debulking
fallopian tube
bevacizumab
Research Site
 (6.9 away) Contact site
  • 0 views
  • 19 Sep, 2021
  • +89 other locations
Study Assessing the Efficacy and Safety of Alpelisib + Nab-paclitaxel in Subjects With Advanced TNBC Who Carry Either a PIK3CA Mutation or Have PTEN Loss

The purpose of this study is to determine whether treatment with alpelisib in combination with nab-paclitaxel is safe and effective in subjects with advanced triple negative breast cancer (aTNBC) who carry either a PIK3CA mutation (Study Part A) or have PTEN loss (Study Part B1) or PTEN loss without PIK3CA …

paclitaxel
PIK3CA
metastasis
PTEN
mammogram
Novartis Investigative Site
 (8.0 away) Contact site
  • 5 views
  • 19 Sep, 2021
  • +153 other locations
Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme

INTRAGO II resembles a multicentric, prospective, randomized, 2-arm, open-label clinical phase III trial which tests if the median progression-free survival (PFS) of patients with newly diagnosed glioblastoma multiforme (GBM) can be improved by the addition of intraoperative radiotherapy (IORT) to standard radiochemotherapy.

temozolomide
complete resection
renal function test
Clinica Delgado-AUNA
 (7.8 away) Contact site
  • 320 views
  • 09 May, 2021
  • +18 other locations
Evaluating Newly Approved Drugs for Multidrug-resistant TB

endTB Clinical Trial a Phase III, randomized, controlled, open-label, non-inferiority, multi-country trial evaluating the efficacy and safety of five new, all-oral, shortened regimens for multidrug-resistant tuberculosis (MDR-TB).

clofazimine
linezolid
vasectomy
delamanid
bedaquiline
Socios En Salud
 (5.6 away) Contact site
  • 223 views
  • 19 Sep, 2021
  • +7 other locations
A Study to Determine the Efficacy Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) Metronidazole (MTZ) Versus Meropenem (MER) Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria.

A Phase 3 comparative study to determine the efficacy, safety and tolerability of Aztreonam-Avibactam (ATM-AVI) Metronidazole (MTZ) versus Meropenem (MER) Colistin (COL) for the treatment of serious infections due to Gram negative bacteria.

metronidazole
antibiotics
meropenem
colistin
ATM
Clinica Internacional - Unidad de Investigacion de la Clinica Internacional
 (6.4 away) Contact site
  • 190 views
  • 19 Sep, 2021
  • +189 other locations
Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A

The primary purpose of the study is to compare the efficacy and safety of canakinumab versus placebo as adjuvant therapy in adult subjects with stages AJCC/UICC v. 8 II -IIIA and the subset of IIIB (T>5cm N2 disease) completely resected (R0) non-small cell lung cancer (NSCLC).

alopecia
systemic therapy
lung carcinoma
Novartis Investigative Site
 (7.7 away) Contact site
  • 645 views
  • 19 Sep, 2021
  • +416 other locations
A Study of Atezolizumab Plus Nab-Paclitaxel in the Treatment of Unresectable Locally Advanced or Metastatic PD-L1-Positive Triple-Negative Breast Cancer

Study MO39874 is an open-label, phase IIIb, single arm, multicenter study conducted in participants with unresectable locally advanced or metastatic PD-L1-positive Triple-Negative Breast Cancer (TNBC) who have not received chemotherapy for their unresectable locally advanced or metastatic disease.

serum pregnancy test
adenocarcinoma of the breast
erbb2
programmed cell death 1 ligand 1
HER2
Hospital Central Fap Juan Benavides Dorich; Oncology
 (3.9 away) Contact site
  • 147 views
  • 19 Sep, 2021
  • +163 other locations
Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)

The purpose of this study is to assess the efficacy and safety of treatment with definitive chemoradiotherapy (dCRT) + pembrolizumab (MK-3475) compared to treatment with dCRT + placebo with respect to Overall Survival (OS) and Event-free Survival (EFS) in: participants with esophageal squamous cell carcinoma (ESCC), participants whose tumors express …

leucovorin
pembrolizumab
chemotherapy regimen
mk-3475
carcinoma
Clinica San Gabriel ( Site 0142)
 (2.8 away) Contact site
  • 32 views
  • 19 Sep, 2021
  • +152 other locations
Doravirine/Islatravir (DOR/ISL) in Heavily Treatment-Experienced (HTE) Participants for Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591A-019)

This is a 2-part, phase 3 clinical study evaluating the antiretroviral activity and safety/tolerability of islatravir (ISL), doravirine (DOR), and a fixed dose combination (FDC) of DOR/ISL (also known as MK-8591A) in heavily treatment-experienced (HTE) participants with human immunodeficiency virus type 1 (HIV-1) infection. It is hypothesized that the percentage …

Policlinico Universidad Nacional Mayor de San Marcos ( Site 4501)
 (3.7 away) Contact site
  • 118 views
  • 19 Sep, 2021
  • +102 other locations
Study of Chemoradiotherapy With or Without Pembrolizumab (MK-3475) For The Treatment of Locally Advanced Cervical Cancer (MK-3475-A18/KEYNOTE-A18/ENGOT-cx11/GOG-3047)

The purpose of this study is to evaluate the efficacy and safety of pembrolizumab plus concurrent chemoradiotherapy compared to placebo plus concurrent chemoradiotherapy in participants with locally advanced cervical cancer. The primary hypotheses are that pembrolizumab plus concurrent chemoradiotherapy is superior to placebo plus concurrent chemoradiotherapy with respect to progression-free …

pembrolizumab
external beam radiation therapy
brachytherapy
adenosquamous carcinoma
carcinoma
Hospital Nacional Daniel Alcides Carrion ( Site 0293)
 (1.1 away) Contact site
  • 87 views
  • 19 Sep, 2021
  • +165 other locations